Bioanalytical Systems, Inc. (NASDAQ:BASI) Sees Significant Decrease in Short Interest

Bioanalytical Systems, Inc. (NASDAQ:BASI) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 12,700 shares, a drop of 5.2% from the May 30th total of 13,400 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 14,900 shares, the short-interest ratio is currently 0.9 days.

NASDAQ BASI opened at $2.02 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.63 and a quick ratio of 0.54. Bioanalytical Systems has a 1-year low of $1.18 and a 1-year high of $2.17. The company has a 50 day simple moving average of $1.99.

Bioanalytical Systems (NASDAQ:BASI) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.06) earnings per share for the quarter. The business had revenue of $9.34 million during the quarter. Bioanalytical Systems had a negative net margin of 2.82% and a negative return on equity of 3.12%.

About Bioanalytical Systems

Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products.

Read More: Technical Indicators – What is a Golden Cross?

Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.